Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

Print Email

Stocks were mixed on Tuesday morning as the earnings reports start to flow and as government offices begin to reopen after a one-day closure. The bull market is now almost nine years old, and the trend that keeps winning is for investors to buy on pullbacks. Now it’s time to decide how to position portfolios for 2018 and beyond.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for investors and traders alike. Some of these analyst reports and research reports cover stocks to buy. Other reports cover stocks to sell or to avoid.

Additional color and commentary has been added on most of the daily analyst reports. The consensus analyst price targets mentioned and other valuation metrics are from the Thomson Reuters sell-side research service.

24/7 Wall St. has also identified 10 top technology giants, actually nine after Netflix, that analysts have grown more bullish for strong earnings and guidance ahead of their formal earnings reports in the next couple of weeks.

These were the top analyst upgrades, downgrades and other research calls from Tuesday, January 23, 2018.

Amgen Inc. (NASDAQ: AMGN) was raised to Buy from Hold and assigned a $220 price target at Argus. Shares closed up 1.6% at $192.33 on Monday and were indicated up 0.8% at $193.90 on Tuesday. The biotech giant has a 52-week trading range of $150.38 to $192.57 and a consensus analyst target price of $192.60.

Caterpillar Inc. (NYSE: CAT) was raised to Buy from Neutral at Seaport Global, and the price target of $195 compares with a prior closing price of $170.90. Caterpillar has a 52-week range of $90.34 to $173.24 and a consensus price target of $167.04.

CRISPR Therapeutics A.G. (NASDAQ: CRSP) was raised to Buy from Hold with a $45 price target (versus a $33.75 prior close) at SunTrust Robinson Humphrey. CRISPR has a 52-week range of $16.51 to $34.18 and had a consensus price target of $27.33.

Danaher Corp. (NYSE: DHR) was started as Buy with a $116 price target (versus a $99.97 close) at UBS. The 52-week range is $78.97 to $100.88 and the consensus price target is $102.00.

DCP Midstream L.P. (NYSE: DCP) was downgraded to Neutral from Buy with a $40 price objective (versus a $41.99 close) at Merrill Lynch.

Dick’s Sporting Goods Inc. (NYSE: DKS) was raised to Positive from Neutral with a $41 price target (versus a $34.62 close) at Susquehanna. It has a 52-week range of $23.88 to $54.03, and it had a consensus price target of $33.08.

Diamond Offshore Drilling Inc. (NYSE: DO) was downgraded to Underweight from Equal Weight with a $13 price target (versus a $19.92 close) at Barclays. The 52-week range is $10.06 to $20.41. The consensus analyst target is $14.49.

Dollar General Corp. (NYSE: DG) was raised to Outperform from Underperform with a $117 price target (versus a $102.27 close) at Wells Fargo. It has a 52-week range of $65.97 to $102.30 and a consensus price target of $101.00.

Dover Corp. (NYSE: DOV) was started as Neutral at UBS.

Duke Energy Corp. (NYSE: DUK) was raised to Outperform from Neutral with an $83 price target (versus a $76.95 close) at Credit Suisse. Duke Energy has a 52-week range of $76.28 to $91.80 and had a consensus price target of $86.04 before this call.

Editas Medicine Inc. (NASDAQ: EDIT) was raised to Buy from Hold with a $45 price target (versus a $34.62 close) at SunTrust Robinson Humphrey. It has a 52-week range of $13.12 to $36.00 and a consensus price target of $33.21.

Emerson Electric Co. (NYSE: EMR) was started as Buy with an $85 price target at UBS. Emerson closed at $73.26, in a 52-week range of $56.77 to $74.45. The consensus price target is $71.12.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.